These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 20226424)

  • 1. Statins in the elderly: what evidence of their benefit in prevention?
    Steg PG; Tissot CM
    Arch Cardiovasc Dis; 2010 Feb; 103(2):61-5. PubMed ID: 20226424
    [No Abstract]   [Full Text] [Related]  

  • 2. Update on statins and other lipid-lowering drugs.
    Miller CA
    Geriatr Nurs; 2001; 22(5):276-7. PubMed ID: 11606910
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of hyperlipidemia in older adults.
    Alexander KP; Blazing MA; Rosenson RS; Hazard E; Aronow WS; Smith SC; Ohman EM
    J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):49-58. PubMed ID: 19124599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achieving vascular risk factor targets: a survey of a London general practice.
    Levine AP; Mikhailidis DP; Moross T; Benson K; Gor M
    Angiology; 2008; 59(1):36-46. PubMed ID: 18319220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease.
    Robson J
    Heart; 2008 Oct; 94(10):1331-2. PubMed ID: 18701534
    [No Abstract]   [Full Text] [Related]  

  • 6. [JUPITER study (2). For now no reason to give statins to more people].
    Koopmans RP
    Ned Tijdschr Geneeskd; 2009 Feb; 153(6):218-9. PubMed ID: 19271439
    [No Abstract]   [Full Text] [Related]  

  • 7. Managing hyperlipidaemia.
    Wang TW
    Practitioner; 2004 Sep; 248(1662):660, 662-8. PubMed ID: 15376551
    [No Abstract]   [Full Text] [Related]  

  • 8. Should you put all diabetic patients on statins?
    Leiter LA
    J Fam Pract; 2007 Apr; 56(4):294-300. PubMed ID: 17403328
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary prevention trials: lessons learned about treating high-risk patients with dyslipidemia without known cardiovascular disease.
    Ferdinand KC
    Curr Med Res Opin; 2005 Jul; 21(7):1091-7. PubMed ID: 16004678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid abnormalities and cardiovascular risk in the elderly.
    Milionis HJ; Elisaf MS; Mikhailidis DP
    Curr Med Res Opin; 2008 Mar; 24(3):653-7. PubMed ID: 18218195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing CVD risk.
    Aranjo C
    Aust Fam Physician; 2008 Sep; 37(9):695. PubMed ID: 18837159
    [No Abstract]   [Full Text] [Related]  

  • 12. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY; Ko SK; Liew D
    Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [JUPITER study, more reason to give statins as preventive measure - commentary].
    Narkiewicz K
    Kardiol Pol; 2009 Mar; 67(3):346-7. PubMed ID: 19469067
    [No Abstract]   [Full Text] [Related]  

  • 14. [Deficits in lipid lowering therapy and achieving target lipid concentrations in patients with high risk of a cardiovascular event].
    Petrus J; Málek F; Dvořák J; Mates M; Kmoníček P; Skalníková V; Neužil P
    Vnitr Lek; 2012 Jun; 58(6):430-3. PubMed ID: 22913234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of international guidelines on the management of cardiovascular risk factors in diabetic patients with peripheral arterial disease.
    Margeta C; Giurgea A; Hammer A; Schlager O; Zehetmayer S; Koppensteiner R; Willfort-Ehringer A
    Int Angiol; 2009 Jun; 28(3):175-80. PubMed ID: 19506537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The application of evidence-based principles of care in older persons (issue 2): management of lipid disorders.
    Zarowitz BJ; Aronow WS; Hollenack K; O'Shea T
    J Am Med Dir Assoc; 2006 Mar; 7(3):173-9. PubMed ID: 16503311
    [No Abstract]   [Full Text] [Related]  

  • 18. [Favorable effects of decreasing lipids in patients with diabetes mellitus].
    Gouni-Berthold I; Krone W
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S252-4. PubMed ID: 17139581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance.
    Rabar S; Harker M; O'Flynn N; Wierzbicki AS;
    BMJ; 2014 Jul; 349():g4356. PubMed ID: 25035388
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease.
    Staels B; Maes M; Zambon A
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):542-53. PubMed ID: 18628776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.